Treloar C - Search Results

1

'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue.

Clay S, Treloar C, Degenhardt L, Grebely J, Christmass M, Gough C, Hayllar J, McDonough M, Henderson C, Crawford S, Farrell M, Marshall A. Clay S, et al. Among authors: treloar c. Int J Drug Policy. 2023 May;115:104002. doi: 10.1016/j.drugpo.2023.104002. Epub 2023 Mar 30. Int J Drug Policy. 2023. PMID: 37003194 Free article.

2

The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.

Hopwood M, Treloar C. Hopwood M, et al. Among authors: treloar c. Int J Drug Policy. 2007 Oct;18(5):374-80. doi: 10.1016/j.drugpo.2006.12.018. Epub 2007 Jan 23. Int J Drug Policy. 2007. PMID: 17854725

3

Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice.

Treloar C, Laybutt B, Jauncey M, van Beek I, Lodge M, Malpas G, Carruthers S. Treloar C, et al. Int J Drug Policy. 2008 Feb;19(1):59-65. doi: 10.1016/j.drugpo.2007.01.005. Epub 2007 Feb 12. Int J Drug Policy. 2008. PMID: 18312820

4

Preventing transitions to injecting amongst young people: what is the role of Needle and Syringe Programmes?

Brener L, Spooner C, Treloar C. Brener L, et al. Among authors: treloar c. Int J Drug Policy. 2010 May;21(3):160-4. doi: 10.1016/j.drugpo.2009.03.003. Epub 2009 May 7. Int J Drug Policy. 2010. PMID: 19427187

5

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia.

Grebely J, Bryant J, Hull P, Hopwood M, Lavis Y, Dore GJ, Treloar C. Grebely J, et al. Among authors: treloar c. J Viral Hepat. 2011 Apr;18(4):e104-16. doi: 10.1111/j.1365-2893.2010.01370.x. Epub 2010 Sep 14. J Viral Hepat. 2011. PMID: 20840350

6

Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.

Treloar C, Hull P, Bryant J, Hopwood M, Grebely J, Lavis Y. Treloar C, et al. Drug Alcohol Depend. 2011 Jul 1;116(1-3):52-6. doi: 10.1016/j.drugalcdep.2010.11.018. Epub 2010 Dec 30. Drug Alcohol Depend. 2011. PMID: 21194852

7

Structural constraints on the training of peer educators in hepatitis C prevention.

Treloar C, Rance J, Laybutt B, Crawford S. Treloar C, et al. Health Educ Res. 2012 Apr;27(2):248-57. doi: 10.1093/her/cyr094. Epub 2011 Oct 10. Health Educ Res. 2012. PMID: 21987474

8

Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.

Treloar C, Hull P, Dore GJ, Grebely J. Treloar C, et al. Drug Alcohol Rev. 2012 Nov;31(7):918-24. doi: 10.1111/j.1465-3362.2012.00468.x. Epub 2012 May 21. Drug Alcohol Rev. 2012. PMID: 22612899

9

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.

Alavi M, Grebely J, Micallef M, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ; Enhancing Treatment for Hepatitis C in Opioid Substitution Settings (ETHOS) Study Group. Alavi M, et al. Among authors: treloar c. Clin Infect Dis. 2013 Aug;57 Suppl 2:S62-9. doi: 10.1093/cid/cit305. Clin Infect Dis. 2013. PMID: 23884068

10

Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.

Treloar C, Rance J, Grebely J, Dore GJ. Treloar C, et al. Drug Alcohol Depend. 2013 Dec 1;133(2):529-34. doi: 10.1016/j.drugalcdep.2013.07.023. Epub 2013 Aug 2. Drug Alcohol Depend. 2013. PMID: 23932843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters